Raffaelli, Bianca
Do, Thien Phu
Chaudhry, Basit Ali
Ashina, Messoud
Amin, Faisal Mohammad
Ashina, Håkan
Article History
Received: 9 August 2023
Accepted: 5 September 2023
First Online: 21 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: B.R. reports personal fees from AbbVie, Eli Lilly, Lundbeck, Novartis, and Teva, and research grants from Novartis, all outside of the submitted work. B.R. reports serving as junior associate editor of The Journal of Headache and Pain, and associate editor of Frontiers In Neurology. T.P.D. has nothing to disclose. B.A.C. has nothing to disclose. M.A. reports receiving personal fees from AbbVie, Amgen, Eli Lilly, Lundbeck, Novartis, Pfizer and Teva Pharmaceuticals, all outside of the submitted work. MA reports serving as associate editor of Cephalalgia, associate editor of The Journal of Headache and Pain, and associate editor of Brain. F.M.A. reports personal fees from Teva, AbbVie, Pfizer, Lundbeck, Novartis and Eli Lilly, all outside of the submitted work. F.M.A. is the current President of the Danish Headache Society and a member of the Board of Directors in the European Headache Federation. F.M.A. serves as associate editor for Frontiers In Pain Research, Frontiers In Neurology, Headache Medicine, and Acta Neurologica Scandinavica; as junior associate editor for Cephalalgia, and as a member of the editorial board of the European Journal of Headache and Pain. H.A. reports personal fees from Lundbeck and Teva, outside of the submitted work.